lenvatinib et pembrolizumab

Mon, 18 Oct 2021 14:00:55 -0400
Lenvatinib, in combination with pembrolizumab, for the treatment of adult patients with advanced or metastatic RCC with no prior systemic therapy for metastatic RCC.